Latest news - Novo Nordisk
WEBAug 6, 2024 · Latest news. 20 September 2024. Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed. Read more. 19 September 2024. Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function. Read more. 06 …
Novo Nordisk CEO testifies at Senate over weight loss drug prices
WEBSep 24, 2024 · Novo Nordisk ’s top executive faced a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars...
Company announcements and press releases - Novo Nordisk
WEBEuropean regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec.
Novo Nordisk to build $4.1 billion North Carolina facility to boost ...
WEBJun 24, 2024 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy,...
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
WEBApr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
News & media - Novo Nordisk
WEBGet an overview of the Novo Nordisk press releases here or subscribe to our news and get it directly in your mailbox when we have news to tell.
Novo's Tough Month Key in Ending Health Stocks' Winning Streak
WEB5 days ago · European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo Nordisk A/S’s upcoming third-quarter results and experimental drug ...
Novo Nordisk to invest $158 million in insulin plant in Brazil
WEB1 day ago · NVO. SAO PAULO (Reuters) - Danish drugmaker Novo Nordisk will invest 864 million reais ($158.2 million) to revamp a plant in Brazil responsible for pumping out a quarter of its insulin production ...
Novo Nordisk expects double-digit growth as it boosts Wegovy …
WEBCOPENHAGEN/LONDON, Jan 31 (Reuters) - Novo Nordisk on Wednesday forecast another year of double-digit growth as the Danish drugmaker began boosting U.S. supplies of its popular weight-loss drug...
Novo Nordisk stock: The company behind Ozempic and Wegovy is now ... - CNN
WEBMar 8, 2024 · Novo Nordisk, once the little-known maker of diabetes drug Ozempic, has ballooned in value as the drug’s off-label use for weight loss has spread. Wegovy, which contains the same active...